Search hospitals > West Virginia > Huntington
Edwards Comprehensive Cancer Center
Claim this profileHuntington, West Virginia 25701
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
165 reported clinical trials
3 medical researchers
Summary
Edwards Comprehensive Cancer Center is a medical facility located in Huntington, West Virginia. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Edwards Comprehensive Cancer Center is involved with conducting 165 clinical trials across 323 conditions. There are 3 research doctors associated with this hospital, such as Mark Ranalli, Maria R. Tria Tirona, and Patricia H. Hardenbergh.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Mark RanalliNationwide Children's Hospital7 years of reported clinical research
Expert in Uterine Tumors
Expert in Neuroblastoma
71 reported clinical trials
125 drugs studied
Maria R. Tria TironaEdwards Comprehensive Cancer Center8 years of reported clinical research
Expert in Lung Cancer
Expert in Skin Cancer
36 reported clinical trials
96 drugs studied
Patricia H. HardenberghShaw Cancer Center7 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
42 drugs studied
Clinical Trials running at Edwards Comprehensive Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Skin Cancer
Prostate Cancer
Testicular cancer
Breast cancer
Ovarian Cancer
Cancer
Ovarian Tumors
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Edwards Comprehensive Cancer Center?
Edwards Comprehensive Cancer Center is a medical facility located in Huntington, West Virginia. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Edwards Comprehensive Cancer Center is involved with conducting 165 clinical trials across 323 conditions. There are 3 research doctors associated with this hospital, such as Mark Ranalli, Maria R. Tria Tirona, and Patricia H. Hardenbergh.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.